Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bazeed, Alaa Y."'
Autor:
Bazeed, Alaa Y.1 (AUTHOR), Day, Candace M.1 (AUTHOR), Garg, Sanjay1 (AUTHOR) sanjay.garg@unisa.edu.au
Publikováno v:
Cancers. Sep2022, Vol. 14 Issue 17, p4257. 36p.
Autor:
Bazeed, Alaa Y.1 (AUTHOR), Essa, Ebtessam A.2 (AUTHOR), Nouh, Ahmed1 (AUTHOR), El Maghraby, Gamal M.2 (AUTHOR)
Publikováno v:
Drug Development & Industrial Pharmacy. Oct2020, Vol. 46 Issue 10, p1676-1683. 8p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mohamed Nasr, Sameh Saber, Alaa Y. Bazeed, Heba A. Ramadan, Asmaa Ebada, Adela Laura Ciorba, Simona Cavalu, Heba I. Elagamy
Publikováno v:
Materials; Volume 15; Issue 9; Pages: 3374
The objective of this study was to enhance the corneal permeation of gatifloxacin (GTX) using cubosomal nanoparticle as a delivery system. Cubosomal nanoparticle loaded with GTX was prepared and subjected for in vitro and in vivo investigations. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f24bba543308aa402ce9babe2f59aba
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 1, Pp 111-120 (2021)
Refereed/Peer-reviewed Background: Cilostazol is an anti-platelets drug with considerable antithrombotic effects in vivo. Therefore, it is widely used by elderly patients. However, it suffers from poor bioavailability due to its low aqueous solubilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d928b02ac1e992e20238ea258fdb30
https://doi.org/10.34172/ps.2020.64
https://doi.org/10.34172/ps.2020.64
Publikováno v:
Drug Development and Industrial Pharmacy. 46:1676-1683
Refereed/Peer-reviewed Objective: The aim of this work was to investigate dry co-grinding of nateglinide with meglumine for enhanced dissolution rate of nateglinide. The study was extended to investigate the effect of this dissolution enhancement on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac27509040014d39b9c40043d704d52
https://doi.org/10.1080/03639045.2020.1820035
https://doi.org/10.1080/03639045.2020.1820035
Pancreatic cancer (PC) remains the seventh leading cause of cancer-related deaths worldwide and the third in the United States, making it one of the most lethal solid malignancies. Unfortunately, the symptoms of this disease are not very apparent des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::314f86a2c218d62babeac0b81972ce8b
https://hdl.handle.net/11541.2/31065
https://hdl.handle.net/11541.2/31065
Publikováno v:
Pharmaceuticals
Volume 14
Issue 8
Pharmaceuticals, Vol 14, Iss 786, p 786 (2021)
Volume 14
Issue 8
Pharmaceuticals, Vol 14, Iss 786, p 786 (2021)
In this study, gliclazide-loaded cubosomal particles were prepared for improving the oral bioavailability and antidiabetic activity of gliclazide. Four formulations of gliclazide-loaded cubosomal nanoparticles dispersions were prepared by the emulsif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950d72b3c866690b2a8c409cb9795664